Immuno-Oncology 2013: Sponsors
Who has already signed up for the Immuno-Oncology 2013 Conference?
ESMO gratefully acknowledges the valuable contribution of the following organisations*:
Route 206 and Province Line Road
08543 Princeton New Jersey
United States of America
Tel : + 33 (0)1 58 83 60 00 (Europe)
Fax : + 33 (0)1 58 83 60 01 (Europe)
Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. Our medicines are helping millions of people around the world in their fight against cancer, cardiovascular disease, diabetes, hepatitis B, HIV/AIDS, psychiatric disorders and rheumatoid arthritis. This event is supported by an unrestricted medical education grant from BMS.
Tel: +41 61 688 11 11
Fax: +41 61 691 93 91
Headquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, infectious diseases, inflammation, metabolism and neuroscience. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Roche’s personalised healthcare strategy aims at providing medicines and diagnostic tools that enable tangible improvements in the health, quality of life and survival of patients. In 2012 Roche had over 82,000 employees worldwide and invested over 8 billion Swiss francs in R&D. The Group posted sales of 45.5 billion Swiss francs. Genentech, in the United States, is a wholly owned member of the Roche Group. Roche is the majority shareholder in Chugai Pharmaceutical, Japan.
*Companies are currently being assigned and this page will be updated over the coming weeks.